chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nausea; Vomiting; Neck pain; Headache; Mental 'fog'; Lethargic; Vivid dreams upon sleeping; This is a spontaneous report from a non-contactable other health professional reporting for herself. A 36-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: El3248), via an unspecified route of administration on 12Jan2021 09:30, on right arm at single dose for COVID-19 immunization. Facility type vaccine was in Hospital. Medical history was reported as none and patient had no known allergies. Concomitant medications were not reported. Historical vaccine included received her first dose of BNT162B2 (Lot number: EK5730) on 22Dec2020 09:15 on Left arm for COVID-19 immunization and had a headache. The patient experienced nausea, vomiting, neck pain, headache, mental 'fog', lethargic and vivid dreams upon sleeping all on 12Jan2021 15:00. No treatment was received for all events. The outcome of all events were resolved with sequel in Jan2021. Patient did not have Covid prior vaccination and Covid was not tested post vaccination.  No follow-up attempts are possible. No further information expected.
High Temperature 101.5 F; Chills; Felt Dizzy; After booster shot she had more than a little Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Felt Dizzy), PAIN IN EXTREMITY (After booster shot she had more than a little Sore Arm), PYREXIA (High Temperature 101.5 F) and CHILLS (Chills) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 065F21A, 044A21A and 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Nov-2021, the patient experienced PAIN IN EXTREMITY (After booster shot she had more than a little Sore Arm). On 10-Nov-2021, the patient experienced DIZZINESS (Felt Dizzy) and CHILLS (Chills). On 11-Nov-2021, the patient experienced PYREXIA (High Temperature 101.5 F). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Pyrexia, at an unspecified dose and frequency. On 12-Nov-2021, PAIN IN EXTREMITY (After booster shot she had more than a little Sore Arm) had resolved. At the time of the report, DIZZINESS (Felt Dizzy), PYREXIA (High Temperature 101.5 F) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Nov-2021, Body temperature: 101.5 (High) Temperature 101.5 F.         Concomitant product use was not provided by the reporter. Patient had Negative  history of COVID.   This case was linked to MOD-2021-386713, MOD-2021-386675 (Patient Link).
pt recv vax & devel pain & stiffness in joints ( all fingers, bilat wrists, thoracic to sacral area of spine);began w/in a wk p/1st inj;
About a week after the first shot, I began losing hair in my facial area, it was minor at first, but has progressed steadily.  Following the second shot, it?s been continued. Now I?be developed a bald spot on the back of my head.
Flu vaccine given on Tuesday 12/6/16. Parent called on Thursday 12/8/16 at 9AM. Area on RVL where vaccine administered red, swollen, warm to touch. Exam in clinic on 12/8/16 Right anterior thigh erythematous warm to touch, 3 inches in size-no other rashes noted.
My right hand swollen may be after the elbow close to the elbow; My right hand swollen may be after the elbow close to the elbow; My right arm started to hurt; last night the right arm continue hurting more than the vaccine itself; Dizzy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61 year-old patient received bnt162b2 (BNT162B2), administered in arm left, administration date 26Feb2021 14:30 (Lot number: EM9809) at the age of 61 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Blood pressure high" (unspecified if ongoing); "the border of diabetes" (unspecified if ongoing), notes: not been treated for it. Concomitant medication(s) included: NORCO; TRAMADOL. The following information was reported: DIZZINESS (non-serious) with onset 26Feb2021, outcome "unknown", described as "Dizzy"; PAIN IN EXTREMITY (non-serious) with onset 26Feb2021 15:45, outcome "unknown", described as "My right arm started to hurt; last night the right arm continue hurting more than the vaccine itself"; PERIPHERAL SWELLING (non-serious), JOINT SWELLING (non-serious) all with onset 27Feb2021, outcome "unknown" and all described as "My right hand swollen may be after the elbow close to the elbow". Therapeutic measures were taken as a result of dizziness, pain in extremity, peripheral swelling, joint swelling.  Additional information: Event onset time for pain arm was reported as 15:45 (also reported as about an hour after/ hour and half later). The patient received Ibuprofen as treatment for the events. Concomitant medications included pain medications.  No follow-up attempts are possible. No further information is expected.
Developed dermatographia. Bouts on body and face. Have had the condition for nearly two months--I have no history of skin conditions or non-seasonal allergies.
fever 102, not relieved by APAP;high pitched prolonged crying for about 24hrs;
Systemic: Body Aches Generalized-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Chills-Medium
no adverse event; PROQUAD with half the dose in one arm and half the dose in the other arm; This spontaneous report has been received from a nurse referring to a patient of unknown age and gender. The patient's concurrent medications, pertinent medical history, drug reactions or allergies were not reported.  On 22-APR-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5 milliliter (strength, route of administration were not reported, lot # T030479 has been verified to be a valid lot number, expiration date was 07-MAR-2022) for prophylaxis, with half the dose in one arm and half the dose in the other arm (product administered at inappropriate site). The patient received the full dose and had no additional adverse event.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On an unknown date in 2012, a pharmacist at a pharmacy administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On an unknown date in 2016, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
This was the J&J booster. The first 24-30 hours post booster where just some fatigue, However my metatarsals, knees, hips, shoulders, hands to include the wrists and metacarpals and elbows and all muscle groups associated with these joints became very painful. I went to a local urgent care on 13Jan22, they said the symptoms I was experiencing would likely hang around 10-14 days. They had me d/c the ibprophen and use tylenol . I'm still having issues all day long. please advise!
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/24/2021 and 4/21/2021. Presented to ER 12/28 due to cough and hypoxic respiratory failure.  Admitted to floor, started therapy for sepsis and pneumonia.  Tested positive for COVID 12/29 started decadron and remdesivir,  continued to decline, transferred to ICU 12/31.  Intubated 1/1.  Completed COVID therapy, but severe respiratory failure continued.  She then developed septic shock with CONS bacteremia. Continued to decline, expired 01/09/22.
Chills and fever starting around 7:00 PM, lightheadedness, near-syncope around 2:00 AM
Pain in arm; back pain; runny nose; fatigue; chills; cold; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 24Jan2021 at single dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced pain in arm, chills, back pain, runny nose, fatigue, cold in Jan2021, the patient wondered how long the side effects will last. AE for symptoms after covid vaccine, hold time too long, cold transferred to PMI. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
have a reaction to second vaccination two weeks later; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (have a reaction to second vaccination two weeks later) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (have a reaction to second vaccination two weeks later). At the time of the report, VACCINATION COMPLICATION (have a reaction to second vaccination two weeks later) outcome was unknown.            Reporter did not allow further contact
On 2/8/2021, 72yr old female with depressive disorder, GAD, HTN, hyperlipidemia, osteopenia was administered COVID-19 Pfizer vaccine  0.3mL in right deltoid (LOT # EM9810).  Patient has several documented allergies including meperidine (hallucinations), oxycodone (hallucinations), clonazepam (hives) and prednisolone (itching).  Patient initially tolerated injection without incident and was sent for post-injection 15min observation.  During 15min observation period, patient developed "difficulty swallowing".  Patient brought back to room to be seen by provider.  Patient noted issue was "mild" and denied any difficulty breathing. Patient able to talk in complete sentences without any evidence of wheezing or stridor.
Five inch red circle around administration site that was hard to touch, 0 itching. Area was tender to touch. Began 2 days after administration and lasted approx 1 week. No treatment required.
Severe reactivation or worsening of psychosis within 24hr after each dose of Pfizer Covid 19 vaccine resulting in multiple hospitalizations after the second dose for psychotic symptoms including suicide attempt. Symptom-free and stable 1 year prior to vaccine dose. Father reporting on behalf of 26yo son. History of schizoaffective disorder since high school mainly social anxiety, and intermittent mild-to moderate depression and mild though blocking. Most recently before vaccine, completely stable for 1 year on maintenance of 60 mg Cymbalta only, finished college with IT degree, started job. Never smoker, never drug/alcohol user. Rapid reactivation to worst symptoms ever experienced after each dose. First episode lasted 3-4 days, occurred within 24hr after first dose. Second episode, ongoing since second dose occurred within 24hr of dose. Extreme paranoia, delusions, auditory and visual hallucinations and suicide attempt, never experienced prior, and requiring multiple hospitalizations. Currently hospitalized.
During first vaccine I had a minor vision issue which went away with in 30 minutes, sore arm felt fine.  After second dose I felt as though I had the flu and stayed in bed for several days, approximately  two weeks later I lost my since of smell, continued severe body aches, extreme fatigue and constant pressure in the back of my head. I'm now several months out and the symptoms are getting worse. Ive always been very healthy, sleep for 6 hours a night and had high energy. Now after 12 hours of sleep I still fall asleep during the day. My headaches are increasing in severity. I can't smell or taste. I'm having joint issues with my jaw and limbs. I keep thinking I'm going to shake this but I'm starting to loose hope.
After patient received the above vaccines, pt stated that she felt ok and was ready to go home. At approx 1:17 pm, noticed that the patient was getting pale in color, and asked patient how she felt.  Patient stated that she felt dizzy. This nurse, went to grab the patient and helped lower the patient to the floor. I immediately called for help. At approx 1:18 pm, more nursing staff (help arrived). At approx 1:19 pm, manual blood pressure taken 100/70, HR 90, and 98% SpO2 saturation on RA. Patient was talking and crying. At approx 1:20 pm, gave the patient some apple juice. Patient drank all the juice and remained sitting upright. At approx 1:30 pm, patient wanted to try standing up and was still talking. At approx 1:34 pm, patient c/o lightheadedness again and sat in chair. At approx 1:38 pm, patient wanted to try standing up again. At approx 1:42 pm, patient walked to the lobby and sat back in chair, while mother checked out. This nurse stayed with patient while mother checked out. Patient was able to walk to her car ok.
On 11/21/98, the pt experienced a local reaction at the injection site. Pt had an approximately 14 cm irregular redness in a circle around injection site. This resolved in a couple of days.
On 10/15/2005 patient first noted a problem with numbness of the right side of her face and went to urgent care.  On 10/13/2005 she continued to have numbness of the right side of her face with vertigo and saw doctor.  It was at this time patient was seen and referred to a neurologist.  On 10/14/2005 patient continued symptoms of numbness of the right side of her face and vertigo.  Neurologist wanted to admit patient to hospital on 10/14/2005, but patient refused at that time.  Neurologist admitted patient to hospital on 10/16/2005.  Tests were done and patient started on high dosage of steroid therapy.  Patient was discharged from the hospital on 10/18/2005 and continued on steroid therapy as an outpatient.  Patient was readmitted to hospital on 10/23/2005 due to a possible reaction from the steroid therapy.  On 10/31/2005 a nurse at the health department called patient to discuss her most recent hospitalization stay and to find out her current signs and symptoms.  Patient stated she was diagnosed as having steroid psychosis on 10/23/2005.  She was started on medication for the psychosis.  While in the hospital an MRI was done which patient stated showed white spots on her brain.  She was discharged from the hospital on 10/25/2005 and continues on oral medication for the psychosis.  She is on no other medication at this time.  She will see Neurologist on Friday, 11/04/2005.  Patient stated she continues to have numbness of the right side of her face.  The vertigo has subsided at this time. 12/05/05 Review of medical records attached to report indicate diagnoses of Bell's Palsy bronchitis at ER visit of 10/12/05; symptom of gait ataxia and diagnoses of encephalomyelitis and encephalitis were noted on 10/27/05; and diagnosis of epilepsy on 11/6/05.  Called & talked with patient on 3-20-07.  Patient states she has nerve damage on the right side of her body with weakness tingling & burning sensation right side of face RUE and RLE.  She c/o's of intermittent veritgo increased with exertion and almost constant dull headache.  She has been unemployed since July 2006 and has filed for disability.
This spontaneous case initially received from other non-health professional on 08-Oct-2018, concerning a 60-year-old, adult female patient. The patient's current condition included hypertension, high cholesterol, gastroesophageal reflux, artificial menopause, hyperlipidemia, allergic rhinitis, indigestion, difficult in swallowing, asthma, tension headache and non-alcoholic fat liver disease. The patient's concomitant medications included ZIAC, CELEBREX, AZOR, PRILOSEC, ADVAIR and PROVENTIL. On 08-Oct-2018, the patient (under age of 65) was administered FLUAD (TIV) [dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 252230, expiry date: 30-Jun-2019] (explicitly coded as inappropriate age at vaccine administration). No adverse events were reported after the vaccine administration. The reporter assessed this case as non-serious.
Appendicitis the next day 5/6/11 after HPV only administered 5/5/11.
soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at the injection site) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included OMEPRAZOLE, GABAPENTIN, AMITRIPTYLINE, LEVOTHYROXINE SODIUM (SYNTHROID), ROSUVASTATIN, HYDROCHLOROTHIAZIDE and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-256810.
Pt recv vax on 10/20/98; on same day pt exp achy feeling
left arm where DTAP and IPV were given had some redness and swelling around shot area. no duration
Temperature 101.3, severe headache, chills, fever, diarrhea, body aches, unable to move left arm, high heart rate, difficulty breathing
COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Sep2022 as dose 1, single (Batch/Lot number: unknown) at the age of 38 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Plaque psoriasis" (unspecified if ongoing); "asthma" (unspecified if ongoing); "environmental allergies" (unspecified if ongoing). The patient did not have any known allergies. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid from 23Jan2023 to 28Jan2023.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This spontaneous report was received from a Nurse refers to a patient of an unknown age and gender. The patient's relevant medical history, concurrent condition and concomitant medication were not reported. On 18-JAN-2016, patient was vaccinated with first dose of GARDASIL 9 injection (unspecified lot number/expiry date and dosage). On 23-MAR-2016, patient was vaccinated with second dose of GARDASIL 9 injection (unspecified lot number/expiry date and dosage). On 18-JUL-2016, the patient was vaccinated with third dose GARDASIL 9 injection, lot # M004116 (expiry date: 12-OCT-2017) 4 days early (unspecified dosage). All dates of administration were confirmed. No adverse effects reported. No Product Quality Complaint (PQC) was involved. Additional information has been requested.
NO ADVERSE EVENT; VARlVAX administered after temperature excursion; This spontaneous report was received from a consumer referring to a patient of unknown age and gender. Information regarding to the patient's medical history, concurrent condition and concomitant medication were not provided.     On 20-JUL-2021, the varicella virus vaccine live (oka/merck)(VARIVAX) (0.5ml, lot # T017685, expiration date 21-MAY-2022; strength and route were unknown) was administered for prophylaxis after temperature excursion (product storage error).      Temperature excursion of this vaccine was 5.9 Fahrenheit degrees for 8 minutes. There was no previous temperature excursion. No additional adverse event was reported. Data logger was involved.
This spontaneous report as received from a registered nurse via a company representative refers to a patient of unknown age and gender. No medical history or concurrent conditions were provided. The nurse reported that on 24-APR-2014, the patient received the first dose of PROQUAD (route and lot number not provided) and the first dose of VARIVAX INJ (route and lot number not provided). No adverse symptoms reported. Additional information has been requested.
The morning after the shot I went to the bathroom, took my AM meds and took my BP which was low 103/66 pulse 95.  I felt a major push to throw up  and so I turned to the commode.  As I started to put my head down, I passed out. A short time later (minutes) I was trying to stand up but was too weak so I called my wife to assist.  We called 911 and within minutes I was off to the hospital.